2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      An ultrasensitive microfluidic approach reveals correlations between the physico-chemical and biological activity of experimental peptide antibiotics

      research-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Antimicrobial resistance challenges the ability of modern medicine to contain infections. Given the dire need for new antimicrobials, polypeptide antibiotics hold particular promise. These agents hit multiple targets in bacteria starting with their most exposed regions—their membranes. However, suitable approaches to quantify the efficacy of polypeptide antibiotics at the membrane and cellular level have been lacking. Here, we employ two complementary microfluidic platforms to probe the structure–activity relationships of two experimental series of polypeptide antibiotics. We reveal strong correlations between each peptide’s physicochemical activity at the membrane level and biological activity at the cellular level. We achieve this knowledge by assaying the membranolytic activities of the compounds on hundreds of individual giant lipid vesicles, and by quantifying phenotypic responses within clonal bacterial populations with single-cell resolution. Our strategy proved capable of detecting differential responses for peptides with single amino acid substitutions between them, and can accelerate the rational design and development of peptide antimicrobials.

          Related collections

          Most cited references55

          • Record: found
          • Abstract: found
          • Article: not found

          Robust growth of Escherichia coli.

          The quantitative study of the cell growth has led to many fundamental insights in our understanding of a wide range of subjects, from the cell cycle to senescence. Of particular importance is the growth rate, whose constancy represents a physiological steady state of an organism. Recent studies, however, suggest that the rate of elongation during exponential growth of bacterial cells decreases cumulatively with replicative age for both asymmetrically and symmetrically dividing organisms, implying that a "steady-state" population consists of individual cells that are never in a steady state of growth. To resolve this seeming paradoxical observation, we studied the long-term growth and division patterns of Escherichia coli cells by employing a microfluidic device designed to follow steady-state growth and division of a large number of cells at a defined reproductive age. Our analysis of approximately 10(5) individual cells reveals a remarkable stability of growth whereby the mother cell inherits the same pole for hundreds of generations. We further show that death of E. coli is not purely stochastic but is the result of accumulating damages. We conclude that E. coli, unlike all other aging model systems studied to date, has a robust mechanism of growth that is decoupled from cell death. Copyright 2010 Elsevier Ltd. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Mode of action of membrane active antimicrobial peptides.

            Water-membrane soluble protein and peptide toxins are used in the defense and offense systems of all organisms, including plants and humans. A major group includes antimicrobial peptides, which serve as a nonspecific defense system that complements the highly specific cell-mediated immune response. The increasing resistance of bacteria to conventional antibiotics stimulated the isolation and characterization of many antimicrobial peptides for potential use as new target antibiotics. The finding of thousands of antimicrobial peptides with variable lengths and sequences, all of which are active at similar concentrations, suggests a general mechanism for killing bacteria rather than a specific mechanism that requires preferred active structures. Such a mechanism is in agreement with the "carpet model" that does not require any specific structure or sequence. It seems that when there is an appropriate balance between hydrophobicity and a net positive charge the peptides are active on bacteria. However, selective activity depends also on other parameters, such as the volume of the molecule, its structure, and its oligomeric state in solution and membranes. Further, although many studies support that bacterial membrane damage is a lethal event for bacteria, other studies point to a multihit mechanism in which the peptide binds to several targets in the cytoplasmic region of the bacteria.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The value of antimicrobial peptides in the age of resistance

              Accelerating growth and global expansion of antimicrobial resistance has deepened the need for discovery of novel antimicrobial agents. Antimicrobial peptides have clear advantages over conventional antibiotics which include slower emergence of resistance, broad-spectrum antibiofilm activity, and the ability to favourably modulate the host immune response. Broad bacterial susceptibility to antimicrobial peptides offers an additional tool to expand knowledge about the evolution of antimicrobial resistance. Structural and functional limitations, combined with a stricter regulatory environment, have hampered the clinical translation of antimicrobial peptides as potential therapeutic agents. Existing computational and experimental tools attempt to ease the preclinical and clinical development of antimicrobial peptides as novel therapeutics. This Review identifies the benefits, challenges, and opportunities of using antimicrobial peptides against multidrug-resistant pathogens, highlights advances in the deployment of novel promising antimicrobial peptides, and underlines the needs and priorities in designing focused development strategies taking into account the most advanced tools available.
                Bookmark

                Author and article information

                Contributors
                camajehangir@gmail.com
                s.pagliara@exeter.ac.uk
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                7 March 2022
                7 March 2022
                2022
                : 12
                : 4005
                Affiliations
                [1 ]GRID grid.8391.3, ISNI 0000 0004 1936 8024, Living Systems Institute, , University of Exeter, ; Stocker Road, Exeter, EX4 4QD UK
                [2 ]GRID grid.8391.3, ISNI 0000 0004 1936 8024, College of Engineering, Mathematics and Physical Sciences, , University of Exeter, ; North Park Road, Exeter, EX4 4QF UK
                [3 ]GRID grid.5335.0, ISNI 0000000121885934, Cavendish Laboratory, Department of Physics, , University of Cambridge, ; JJ Thomson Avenue, Cambridge, CB3 0HE UK
                [4 ]GRID grid.410351.2, ISNI 0000 0000 8991 6349, National Physical Laboratory, ; Hampton Road, Teddington, Middlesex, TW11 0LW UK
                [5 ]GRID grid.83440.3b, ISNI 0000000121901201, London Centre for Nanotechnology, , University College London, ; London, WC1H 0AH UK
                [6 ]GRID grid.13097.3c, ISNI 0000 0001 2322 6764, Department of Physics, , King’s College London, ; Strand Lane, London, WC2R 2LS UK
                [7 ]GRID grid.8391.3, ISNI 0000 0004 1936 8024, College of Life and Environmental Sciences, , University of Exeter, ; Stocker Road, Exeter, EX4 4QD UK
                Article
                7973
                10.1038/s41598-022-07973-z
                8901753
                35256720
                977880df-bc0a-4f78-8f15-1d74589cad9e
                © The Author(s) 2022

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 18 November 2021
                : 28 February 2022
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100010269, Wellcome Trust;
                Award ID: 204909/Z/16/Z
                Award Recipient :
                Funded by: Winton Programme for the Physics of Sustainability
                Funded by: Cambridge-NPL studentship
                Funded by: Trinity-Henry Barlow Scholarship
                Funded by: FundRef http://dx.doi.org/10.13039/501100000266, Engineering and Physical Sciences Research Council;
                Award ID: EP/R513180/1
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100006041, Innovate UK;
                Award ID: 103358
                Funded by: FundRef http://dx.doi.org/10.13039/100011693, Department for Business, Energy and Industrial Strategy, UK Government;
                Funded by: FundRef http://dx.doi.org/10.13039/501100000781, European Research Council;
                Award ID: 647144
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100000265, Medical Research Council;
                Award ID: MCPC17189
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100000268, Biotechnology and Biological Sciences Research Council;
                Award ID: BB/V008021/1
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100000288, Royal Society;
                Award ID: RG180007
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100000936, Gordon and Betty Moore Foundation;
                Award ID: GBMF5514
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100010665, H2020 Marie Skłodowska-Curie Actions;
                Award ID: H2020-MSCA-ITN-2015-675752
                Award Recipient :
                Categories
                Article
                Custom metadata
                © The Author(s) 2022

                Uncategorized
                biochemistry,biological techniques,biophysics,drug discovery,microbiology
                Uncategorized
                biochemistry, biological techniques, biophysics, drug discovery, microbiology

                Comments

                Comment on this article